Understanding the Landscape of Inappropriate PPI Use
Proton pump inhibitors (PPIs) are highly effective medications for suppressing gastric acid, making them invaluable for treating conditions like severe erosive esophagitis and Helicobacter pylori infection. However, their widespread availability and tendency for continued use long after the initial indication has resolved contribute to significant overuse, particularly among the elderly. For older adults, this inappropriate, long-term use can lead to serious adverse health outcomes, highlighting the need to understand its predictors.
The Role of Advanced Age and Polypharmacy
As patients age, they often develop multiple chronic health conditions, leading to polypharmacy, which is the use of multiple medications. This is a primary driver of inappropriate PPI use.
-
Unnecessary Prophylaxis: A frequent predictor of inappropriate PPI use is the prescription for unnecessary ulcer prophylaxis, especially when other medications like non-selective non-steroidal anti-inflammatory drugs (NSAIDs) or antiplatelet agents are prescribed. While these can pose a bleeding risk, not all patients have the necessary GI risk factors to warrant chronic PPI use. In many cases, prophylaxis is continued without re-evaluating the patient's actual risk. In one study, the use of NSAIDs and low-dose aspirin were among the strongest predictors for inappropriate PPI use.
-
Prescribing Cascade: The prescribing cascade occurs when a new medication is prescribed to treat a symptom that is actually a side effect of an existing medication. For example, a PPI might be added to manage gastrointestinal discomfort caused by another drug, and it is then continued long-term, compounding the medication load and risk for the patient.
Cognitive Impairment as a Factor
Cognitive decline and communication deficits can significantly impact the appropriateness of PPI therapy in older adults.
-
Communication Deficits: Patients with conditions like mild cognitive impairment (MCI) or dementia may have difficulty communicating the severity or resolution of their symptoms to their healthcare provider. This can lead to the indefinite continuation of a PPI because the provider lacks clear feedback that the short-term indication has passed.
-
Caregiver Reporting: In some cases, caregivers may report symptoms, but without a full medical history, the provider may continue a PPI based on incomplete information. Studies have found a significantly higher prevalence of inappropriate PPI use in older adults with MCI compared to their cognitively intact peers.
Lack of Indication Review and Deprescribing
One of the most significant predictors of continued inappropriate PPI use is the failure to regularly review and reassess the medication's indication.
-
Hospital-Initiated Prescriptions: A common scenario involves hospital-initiated PPI prescriptions for stress ulcer prophylaxis during a patient's stay. Upon discharge, the PPI is continued without a clear long-term indication and is never later discontinued.
-
Temporary Issues Become Permanent: For many patients, PPIs are initiated for transient issues like dyspepsia or acid reflux. Without a defined endpoint or follow-up plan, these prescriptions are often refilled indefinitely, long after the symptoms have been resolved or could be managed with less aggressive alternatives. A third of short-course PPIs for dyspepsia and a tenth for ulcer prophylaxis were inaccurately continued in one study.
A Comparison of Appropriate vs. Inappropriate PPI Use
| Feature | Appropriate Use | Inappropriate Use |
|---|---|---|
| Duration | Short-term (≤8 weeks) for uncomplicated GERD or ulcer healing | Continued long-term (>8 weeks) without re-evaluation |
| Indication | Documented severe erosive esophagitis, Barrett's esophagus, or active GI bleed | Non-specific dyspepsia, unnecessary ulcer prophylaxis, or managing a symptom of another drug |
| Risk Factors | High-risk NSAID users, history of GI bleed, or significant comorbidities warranting prophylaxis | Low-risk NSAID use without GI risk factors |
| Management | Regular review with a planned deprescribing strategy | Lack of follow-up and automatic prescription renewal |
Potential Harms of Inappropriate PPI Use
Inappropriate long-term PPI use in older patients is associated with a range of potential harms.
- Bone Fractures: Reduced gastric acid production can impair calcium absorption, potentially increasing the risk of osteoporosis-related fractures, especially in the hip.
- Clostridium difficile Infection (CDI): PPIs alter gut microbiota and can increase the risk of CDI, a serious and potentially fatal bacterial infection.
- Nutrient Deficiencies: Long-term use can lead to malabsorption of essential nutrients like magnesium and Vitamin B12, causing neurological issues and other complications.
- Pneumonia: Studies suggest an increased risk of community-acquired pneumonia with long-term PPI use.
Strategies to Reduce Inappropriate Use
Healthcare providers and caregivers can proactively reduce inappropriate PPI use by focusing on preventative and corrective strategies.
Prioritizing Patient and Provider Education
Both patients and healthcare professionals must be aware of the risks and appropriate indications for PPIs.
- Patient Awareness: Informing patients about the purpose and intended duration of their PPI therapy is crucial for empowering them to engage in the deprescribing process.
- Provider Reminders: Integrating point-of-care reminders into electronic medical records can prompt providers to review the need for PPI continuation at each renewal.
Implementing Deprescribing Protocols
For patients without a clear, ongoing indication, a controlled deprescribing process is recommended.
- Collaborative Approach: A multidisciplinary team involving pharmacists, physicians, and nurses can ensure a safe deprescribing plan is followed.
- Tapering the Dose: A step-down approach, such as gradually reducing the dose or switching to alternate-day therapy, can help manage potential rebound acid secretion. Guidance on this can be found in resources such as the NIH's Therapeutics Letter 111 on Deprescribing Proton Pump Inhibitors.
Conclusion
Inappropriate PPI use is a widespread issue in senior care, driven by factors like age, polypharmacy, cognitive impairment, and a lack of consistent medication review. By understanding these predictors, healthcare providers, patients, and caregivers can work together to ensure that PPIs are used only when clinically necessary and for the appropriate duration. Implementing systematic review and deprescribing protocols is essential to mitigate the significant risks associated with long-term, non-indicated PPI therapy, ultimately improving health outcomes for elderly patients.
